Vijaya Diagnostic Centre Q1 FY27 Share Price & Earnings Call Analysis
- Market cap
- ₹14,887 Cr
- P/E
- 79.40
- ROE
- 18.34%
- PEG
- 3.28
- Price to sales
- 17.36
- Debt to equity
- 0.44
- 52W high / low
- ₹1,571 / ₹861
- Sales growth (5Y)
- 16.66%
- EBITDA margin
- 42.23%
- Net profit margin
- 19.78%
- Promoter holding
- 52.46%
- Sales (last year)
- ₹857 Cr
Vijaya Diagnostics Centre limited is a leading diagnostic medicare services provider in Southern India and offers comprehensive services that include nuclear medicine, radiology, laboratory, health check-ups and medical services. The company provides its services across 13 cities through its 81 diagnostic centers and 11 reference laboratories.[1]
Guidance scorecard · Q1 FY27 call
What Vijaya Diagnostic Centre Ltd's management guided
and where it ranks in Healthcare Services
Healthcare Services
RevenueQ1 FY27 call
20–40%- Vijaya Diagnostic Centre plans to commission 9 new hub centres and 10-12 spoke centres in the upcoming year, continuing expansion in new markets.
- The company expects to sustain high double-digit revenue growth for FY27, building on a strong Q1 growth of 23%.
- Mid to long-term sustainable revenue growth is targeted around 15% annually over the next 3 to 5 years.
- Hyderabad cluster, which contributes ~67% of revenue, grew 17% year-on-year despite maturity, indicating strong organic growth.
- New tier-2 and metro locations like Rajahmundry, Tirupati, Kammam, Bangalore, Pune, and Kolkata are outperforming expectations, often breaking even within 2 quarters.
- Expansion focus includes dense networks in Pune, Bangalore, and Kolkata with plans to add 15 hubs across these metros over 12 months.
2 more points from Vijaya Diagnostic Centre Ltd's call on revenue
Create a free account to keep reading this call
MarginsQ1 FY27 call
FlatSee what Vijaya Diagnostic Centre Ltd said on margins — free account, 30 seconds.
CapexQ1 FY27 call
Planned- Planned capex of approximately INR 190 to 195 crores over the next 12 months.
- Commissioning of 9 new hub centres and 10 to 12 spoke centres; 2 hubs and 6 spokes already commissioned in the current year.
- Major capex includes INR 30 crores for a state-of-the-art hub facility in JP Nagar, Bangalore, featuring advanced imaging equipment and a central lab.
- Acquisition of land (~INR 8-10 crores) in a key medical hub in Andhra Pradesh to set up a new state-of-the-art hub centre due to unavailability of leased properties.
2 more points from Vijaya Diagnostic Centre Ltd's call on capex
Create a free account to keep reading this call
FundraisingQ1 FY27 call
See what Vijaya Diagnostic Centre Ltd said on fundraising — free account, 30 seconds.
Order bookQ1 FY27 call
Ask what Vijaya Diagnostic Centre Ltd said on the order book →
Full Q1 FY27 analysisRanges are what management guided for revenue growth and margins on the latest earnings call. Not investment advice, and not a forecast of returns.
Potential multibaggers · Q2 FY27
Potential multibaggers in Healthcare Services
on management's own guidance
- Strong growth2
- Strong growth1
- Aster DM Quality Care LtdGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Peers
Healthcare Services companies ranked on guidance
| # | Company | Revenue guided | Margin guided | Market cap | P/E |
|---|---|---|---|---|---|
| 1 | 40%+ | Up 2%+ | ₹903 Cr | — | |
| 2 | 40%+ | Flat | ₹583 Cr | 22.2 | |
| 3 | Aster DM Quality Care Ltd | 20–40% | Up 2%+ | ₹58,782 Cr | 162.9 |
| 4 | 20–40% | Up 0–2% | ₹1,730 Cr | 17.5 | |
| 5 | 20–40% | Up 0–2% | ₹580 Cr | 11.9 | |
| 6 | 20–40% | Flat | ₹1.13L Cr | 53.9 |
Sign up free to see every company in the sector ranking and track Vijaya Diagnostic Centre Ltd.
Pro shows every company guiding 40%+ revenue growth →Full Healthcare Services rankingFinancials of Vijaya Diagnostic Centre Ltd
Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of Vijaya Diagnostic Centre Ltd
Quarterly Results
Quarter-by-quarter operating performance
| Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 121 | 121 | 139 | 133 | 155 | 156 | 183 | 169 | 173 | 188 | 202 | 205 | 219 |
| Expenses + | 72 | 73 | 82 | 80 | 92 | 95 | 107 | 102 | 104 | 115 | 120 | 119 | 124 |
| Operating Profit | 49 | 48 | 57 | 52 | 63 | 61 | 76 | 67 | 69 | 74 | 82 | 86 | 96 |
| OPM % | 41% | 40% | 41% | 39% | 41% | 39% | 42% | 40% | 40% | 39% | 41% | 42% | 44% |
| Other Income + | 5 | 6 | 7 | 3 | 3 | 4 | 5 | 5 | 5 | 7 | 6 | 5 | 2 |
| Interest | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 7 | 7 | 7 | 8 | 9 | 9 |
| Depreciation | 11 | 12 | 14 | 15 | 16 | 17 | 17 | 18 | 19 | 21 | 22 | 24 | 24 |
| Profit before tax | 36 | 35 | 45 | 35 | 44 | 42 | 57 | 47 | 47 | 52 | 58 | 58 | 64 |
| Tax % | 24% | 26% | 25% | 25% | 23% | 25% | 26% | 24% | 26% | 26% | 25% | 26% | 25% |
| Net Profit + | 28 | 26 | 34 | 26 | 34 | 32 | 42 | 35 | 35 | 39 | 43 | 43 | 48 |
| EPS in Rs | 2.69 | 2.57 | 3.26 | 2.53 | 3.27 | 3.06 | 4.10 | 3.43 | 3.40 | 3.76 | 4.21 | 4.20 | 4.66 |
Financials of Vijaya Diagnostic Centre Ltd
Profit & Loss
Annual income statement trend
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Sales + | 251 | 293 | 339 | 377 | 462 | 459 | 548 | 681 | 814 |
| Expenses + | 171 | 184 | 206 | 211 | 259 | 277 | 327 | 408 | 477 |
| Operating Profit | 80 | 108 | 133 | 166 | 204 | 182 | 221 | 273 | 337 |
| OPM % | 32% | 37% | 39% | 44% | 44% | 40% | 40% | 40% | 41% |
| Other Income + | 7 | 10 | 15 | 12 | 13 | 14 | 19 | 17 | 21 |
| Interest | 5 | 14 | 15 | 15 | 16 | 21 | 24 | 27 | 33 |
| Depreciation | 26 | 40 | 49 | 50 | 53 | 62 | 57 | 71 | 92 |
| Profit before tax | 55 | 65 | 83 | 112 | 147 | 114 | 159 | 193 | 233 |
| Tax % | 37% | 29% | 25% | 24% | 25% | 25% | 25% | 26% | 26% |
| Net Profit + | 35 | 46 | 63 | 85 | 111 | 85 | 120 | 144 | 173 |
| EPS in Rs | 77.44 | 101.29 | 138.00 | 18.64 | 10.76 | 8.29 | 11.61 | 13.94 | 16.81 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 9% | 12% | 9% | 14% | 12% |
Financials of Vijaya Diagnostic Centre Ltd
Balance Sheet
Capital structure and asset base
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5 | 5 | 5 | 5 | 10 | 10 | 10 | 10 | 10 |
| Reserves | 157 | 203 | 270 | 354 | 458 | 535 | 647 | 785 | 947 |
| Borrowings + | 33 | 146 | 161 | 141 | 183 | 248 | 259 | 320 | 423 |
| Other Liabilities + | 39 | 53 | 46 | 41 | 62 | 61 | 66 | 158 | 127 |
| Total Liabilities | 234 | 406 | 482 | 541 | 713 | 853 | 983 | 1,274 | 1,507 |
| Fixed Assets + | 119 | 259 | 272 | 268 | 370 | 524 | 742 | 865 | 1,070 |
| CWIP | 3 | 3 | 10 | 9 | 34 | 28 | 9 | 70 | 34 |
| Investments | 73 | 69 | 55 | 28 | 54 | 139 | 109 | 185 | 228 |
| Other Assets + | 39 | 76 | 146 | 236 | 255 | 163 | 123 | 154 | 174 |
| Total Assets | 234 | 406 | 482 | 541 | 713 | 853 | 983 | 1,274 | 1,507 |
Financials of Vijaya Diagnostic Centre Ltd
Cash Flows
Operating, investing and financing cash movement
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 62 | 91 | 106 | 130 | 158 | 165 | 183 | 224 | 271 |
| Cash from Investing Activity + | -98 | -90 | -31 | -130 | -123 | -110 | -141 | -182 | -174 |
| Cash from Financing Activity + | -8 | -7 | -30 | -49 | -31 | -42 | -45 | -52 | -69 |
| Net Cash Flow | -44 | -6 | 46 | -49 | 4 | 13 | -2 | -9 | 27 |
| Free Cash Flow | 32 | 31 | 69 | 98 | 37 | 40 | 99 | 132 | 91 |
| CFO/OP | 103% | 101% | 98% | 97% | 97% | 105% | 98% | 97% | 96% |
Financials of Vijaya Diagnostic Centre Ltd
Ratios
Working capital efficiency and return ratios
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 12 | 11 | 9 | 6 | 8 | 8 | 11 | 8 | 9 |
| Inventory Days | 24 | 20 | 23 | 17 | 22 | 13 | 29 | 21 | 19 |
| Days Payable | 176 | 196 | 180 | 142 | 110 | 172 | 184 | 143 | 145 |
| Cash Conversion Cycle | -140 | -165 | -149 | -118 | -81 | -152 | -144 | -114 | -117 |
| Working Capital Days | -41 | -51 | -49 | -26 | -34 | -36 | -29 | -48 | 65 |
| ROCE % | 28% | 23% | 27% | 28% | 18% | 20% | 21% | 21% |
Guidance history
How Vijaya Diagnostic Centre Ltd's guidance has moved, call by call
| Call | Revenue | Margins | Capex | Fundraising | Order book |
|---|---|---|---|---|---|
| Q1 FY27 call → | 20–40% | Flat | Planned | — | — |
| Q4 FY26 call → | 10–20% | Flat | Planned | — | Rising |
| Q3 FY26 call → | 10–20% | Flat | Planned | — | — |
| Q2 FY26 call → | 10–20% | Flat | Planned | — | — |
What management guided on each call, newest first. Not investment advice, and not a forecast of returns.
Momentum score · price trend
82 out of 100 — Strengthening
Over the past year its share price has done better than most of the stocks we track.
| Period | Share price change | Better than … of 1,910 stocks |
|---|---|---|
| Last 12 months | +45.3% | 84% |
| Last 6 months | +28.0% | 80% |
| Last 3 months | +7.5% | 79% |
How we calculate it
“Better than 30%” means that over that period the share price did better than 30 out of every 100 stocks we track (1,910 Indian companies worth ₹500 Cr or more, with at least a year of prices).
The score weighs the longer periods more: 40% × 12-month + 40% × 6-month + 20% × 3-month. For Vijaya Diagnostic Centre Ltd: 0.4 × 84 + 0.4 × 80 + 0.2 × 79 = 82.
Strengthening is 70 and above, Steady 40 to 70, Cooling below 40. Scores are recalculated every night after the market closes.
Full methodology →This describes only how the share price has moved up to 30 Oct 2026, compared with other stocks. It says nothing about the business, and it is not a prediction, a price target or a recommendation to buy or sell.
Continue your research
What Vijaya Diagnostic Centre Ltd's management said in earlier quarters
- Q3 FY26 earnings call analysis →
- Q1 FY27 earnings call analysis →
- Q4 FY26 earnings call analysis →
- Q1 FY26 earnings call analysis →
- Q4 FY25 earnings call →
- Q2 FY25 earnings call →
- Q1 FY25 earnings call →
- Q4 FY24 earnings call →
- Q3 FY24 earnings call →
- Q2 FY24 earnings call →
- Q1 FY24 earnings call →
- Q4 FY23 earnings call →
Others in Healthcare Services this season
- Narayana Hrudayalaya Ltd (Q2 FY27)
Consolidated operating revenue for Q2 FY27: ₹28,440 Mn, up 73.0% YoY (Page 15, 16). Key investor presentation takeaways from Narayana Hrudayalaya Ltd's Q2 FY27
- Artemis Medicare Services Ltd (Q2 FY27)
Q2 FY27 consolidated revenue from operations: INR 31,104 Lacs, up 13.2% YoY (Page 39, 40, 20). Key investor presentation takeaways from Artemis Medicare Service
- Max Healthcare Institute Ltd (Q2 FY27)
Q2 FY27 Gross Revenue: ₹3,219 Cr, up 20% YoY (Page 4, 17) . Key investor presentation takeaways from Max Healthcare Institute Ltd's Q2 FY27 investor presentatio
- Indegene Ltd (Q2 FY27)
Revenue from operations for Q2 FY27: INR 11,223 million, up 39.5% YoY (Page 23, 15, 4) . Key investor presentation takeaways from Indegene Ltd's Q2 FY27 investo